How much cash does Phibro Animal Health generate?

Phibro Animal Health (PAHC) generated $66.1M in operating cash flow over the trailing twelve months.

What is Phibro Animal Health's free cash flow?

After $53.4M of capital expenditures, Phibro Animal Health's free cash flow was $12.8M over the trailing twelve months, down 74.0% year over year.

Where does Phibro Animal Health's cash flow data come from?

Every line is extracted from Phibro Animal Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Phibro Animal Health PAHC Cash Flow Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q3 '26	TTM Q2 '26	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25
Net income	$95.23M+200%	$92.09M+377%	$67.82M+290%	$48.26M+1,898%	$31.79M+142%
Depreciation and amortization	$50.58M+19.3%	$50.75M+30.2%	$49.43M+36.1%	$45.61M+26.1%	$42.4M+19.3%
Stock-based compensation	$1.36M+90.1%	$1.13M+68.1%	$877K+53.1%	$717K+50.9%	$717K—
Deferred income taxes	——	——	——	——	-$18.48M-87.0%
Amortization of debt issuance costs	$2.29M+34.4%	$2.29M+64.5%	$2.22M+93.5%	$2.02M+93.8%	$1.7M+71.5%
Impairment charges	——	——	——	——	——
Change in accounts receivable	——	$15.73M-67.8%	$53.05M+333%	$55.21M+536%	$40.97M—
Change in inventories	$98.7M+233%	$93.11M+555%	$65.31M+2,731%	$44.29M+1,777%	$29.6M—
Change in accounts payable	——	——	$39.62M—	$45.56M—	$46.84M—
Change in accrued liabilities	——	——	$37.19M+157%	$47.36M+289%	$30.53M+1,309%
Change in other assets	——	——	——	——	——
Other working capital changes	$1.84M-74.3%	$1.57M-71.4%	$1.66M-52.9%	$1.64M-21.7%	$7.13M+232%
Net cash from operating activities	$66.13M-24.2%	$93.08M+67.6%	$76.8M-8.6%	$80.12M-8.5%	$87.28M+9.9%
Capital expenditures	$53.36M+39.6%	$45.79M+13.9%	$42.52M-1.9%	$38.29M-7.1%	$38.22M-2.1%
Acquisitions, net of cash acquired	——	——	——	——	——
Purchases of investments	$41.03M—	——	——	——	——
Proceeds from maturities/sales of investments	$28.5M-41.3%	$19M-71.0%	$52M-11.1%	$49M-20.4%	$48.52M—
Other investing activities	——	——	——	——	——
Net cash from investing activities	-$62.04M+78.7%	-$63.48M+76.7%	-$306.77M-731%	-$288.69M-485%	-$290.77M-476%
Dividends paid	$19.46M+0.1%	$19.46M+0.1%	$19.45M+0.1%	$19.45M0.0%	$19.45M0.0%
Proceeds from issuance of debt	——	——	——	——	——
Repayments of debt	$251M-62.7%	$289M-53.2%	$415M-11.1%	$621M+158%	$673M+209%
Payment of debt issuance costs	——	——	——	——	——
Net cash from financing activities	——	——	——	——	——
Effect of exchange rate changes on cash	——	——	——	——	——
Net increase (decrease) in cash	——	——	——	——	——
Interest paid	——	——	——	$32.07M+85.9%	$28.37M+71.1%
Income taxes paid	——	——	——	$13.4M-13.2%	$13.91M-16.6%
Acquisition Related Items	——	$6M—	——	——	——
Amortization expense related to capitalized debt issuance costs	$2.29M+34.4%	$2.29M+64.5%	$2.22M+93.5%	$2.02M+93.8%	$1.7M+71.5%
Asset write-downs	——	——	——	——	——
Unrealized Gain (Loss), Foreign Currency Transaction, before Tax	——	——	——	——	——
Accrued expenses and other liabilities	——	——	$37.19M+157%	$47.36M+289%	$30.53M+1,309%
Increase (Decrease) in Prepaid Expense and Other Assets	——	$3.35M+199%	$15.67M+217%	$16.35M+248%	$109K—
Other Noncash Income (Expense)	$1.84M-74.3%	$1.57M-71.4%	$1.66M-52.9%	$1.64M-21.7%	$7.13M+232%
Payment for (Proceeds from) Other Investing Activity	——	——	——	——	——
Payments to Acquire Short-Term Investments	$41.03M—	——	——	——	——
Proceeds from Maturities, Prepayments and Calls of Short-Term Investments	$28.5M-41.3%	$19M-71.0%	$52M-11.1%	$49M-20.4%	$48.52M—
Payments For Insurance Premium Financing And Other Short Term Debt Financing Activities	$7.53M-10.9%	$7.46M—	$7.35M—	$6.56M—	$8.46M—
Payments Of Debt Issuance Costs	——	——	——	——	——
Repayments of Long-Term Lines of Credit	$251M-62.7%	$289M-53.2%	$415M-11.1%	$621M+158%	$673M+209%
Accrued payables for capital expenditures	——	——	——	$6.85M+189%	$5.73M+132%
Proceeds From Issuance Of Other Long Term Debt	——	——	——	——	——
Proceeds From Long Term Lines Of Credit	$274M-54.3%	$282M-51.5%	$351M-28.7%	$532M+92.8%	$600M+216%
Income Taxes Paid, Net	——	——	——	$13.4M-13.2%	$13.91M-16.6%
Free cash flow	$12.77M-74.0%	$47.29M+209%	$34.29M-15.7%	$41.83M-9.8%	$49.06M—
Free cash flow	$12.77M-74.0%	$47.29M+209%	$34.29M-15.7%	$41.83M-9.8%	$49.06M—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Phibro Animal Health.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

How much cash does Phibro Animal Health generate?: Phibro Animal Health (PAHC) generated $66.1M in operating cash flow over the trailing twelve months.
What is Phibro Animal Health's free cash flow?: After $53.4M of capital expenditures, Phibro Animal Health's free cash flow was $12.8M over the trailing twelve months, down 74.0% year over year.
Where does Phibro Animal Health's cash flow data come from?: Every line is extracted from Phibro Animal Health's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.